Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells.
about
Molecular Mechanisms of the Anti-Obesity and Anti-Diabetic Properties of FlavonoidsMechanisms of Body Weight Reduction by Black Tea PolyphenolsPP2A mediated AMPK inhibition promotes HSP70 expression in heat shock responseImpact of dietary polyphenols on carbohydrate metabolism.Lipotoxicity in HepG2 cells triggered by free fatty acidsCaMKKβ is involved in AMP-activated protein kinase activation by baicalin in LKB1 deficient cell linesAnthocyanin inhibits high glucose-induced hepatic mtGPAT1 activation and prevents fatty acid synthesis through PKCζ.Resveratrol enhances palmitate-induced ER stress and apoptosis in cancer cellsHigh-cocoa polyphenol-rich chocolate improves blood pressure in patients with diabetes and hypertension.Ethanolic Extract of Vitis thunbergii Exhibits Lipid Lowering Properties via Modulation of the AMPK-ACC Pathway in Hypercholesterolemic Rabbits.Bai-Hu-Jia-Ren-Shen-Tang Decoction Reduces Fatty Liver by Activating AMP-Activated Protein Kinase In Vitro and In Vivo.Ginsenoside Rb1 reduces fatty liver by activating AMP-activated protein kinase in obese rats.Targeting AMPK signaling in combating ovarian cancers: opportunities and challenges.Proteomic analysis of the inhibitory effect of epigallocatechin gallate on lipid accumulation in human HepG2 cellsAnti-inflammatory activity of N-(3-florophenyl)ethylcaffeamide in micep73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene.Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance.Long-term baicalin administration ameliorates metabolic disorders and hepatic steatosis in rats given a high-fat diet.Pathogenic obesity and nutraceuticals.Molecular mechanisms for anti-aging by natural dietary compounds.Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease.Plant-derived food ingredients for stimulation of energy expenditure.Chemoprevention of nonalcoholic fatty liver disease by dietary natural compounds.A natural solution for obesity: bioactives for the prevention and treatment of weight gain. A review.Atheroprotective effects of (poly)phenols: a focus on cell cholesterol metabolism.Natural antioxidants for non-alcoholic fatty liver disease: molecular targets and clinical perspectives.Research progress on theaflavins: efficacy, formation, and preparation.Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery.Chloroquine-mediated lysosomal dysfunction enhances the anticancer effect of nutrient deprivation.Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway.An active part of Artemisia sacrorum Ledeb. attenuates hepatic lipid accumulation through activating AMP-activated protein kinase in human HepG2 cells.Modulatory effects of black v. green tea aqueous extract on hyperglycaemia, hyperlipidaemia and liver dysfunction in diabetic and obese rat models.Antilipotoxicity Activity of Osmanthus fragrans and Chrysanthemum morifolium Flower Extracts in Hepatocytes and Renal Glomerular Mesangial Cells.Polyphenols and Oxidative Stress in Atherosclerosis-Related Ischemic Heart Disease and Stroke.Flavonoids, Dairy Foods, and Cardiovascular and Metabolic Health: A Review of Emerging Biologic Pathways.Oolong, black and pu-erh tea suppresses adiposity in mice via activation of AMP-activated protein kinase.Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.Diabetes and Alzheimer's Disease: Can Tea Phytochemicals Play a Role in Prevention?Sorghum extract exerts cholesterol-lowering effects through the regulation of hepatic cholesterol metabolism in hypercholesterolemic mice.
P2860
Q26752387-5C778DC2-5D8F-4B03-A2D3-4D3420B56405Q28072852-F2DCA3FD-7622-4391-A63D-422CE93551E3Q33721815-376C4526-1571-4CC5-B2A2-87AD6D871891Q33853862-22AB0885-2C8A-432E-A72D-3E8BE0F891F3Q33926763-46F435ED-76F3-42E1-9E60-056F089C7B77Q34460721-E8E4E3BD-D956-4CEC-BC43-CC947A4460C7Q34776293-C3B083DE-9639-4850-8825-A4D5FE7F3429Q35462357-F977B9CA-E896-40F3-9780-4022BF4BACDFQ35698560-9C4CDD53-EC4F-44C7-8E0B-468618A9F44DQ35872279-A80A5544-1A31-415E-83EE-7E48C5EC7364Q36174315-11FACEB6-8479-4926-AD7A-0893B76D9F6FQ36754833-DFFEDC14-3209-46B8-95DA-27FD52A3099BQ36949580-5C12CFF8-E595-4038-A88D-9C0C3DC20FA5Q37046184-FF35F35A-E68E-411E-95BF-050347B59E93Q37139014-5876A3BF-E446-41F6-AA21-EB6AC389AC66Q37163723-88D75DA9-1CB7-4917-8D77-42933D302D97Q37529570-9E37A914-7E64-4091-B8C0-3F2E6EB3406DQ37729289-170CD4DC-CB6B-4D44-960B-5870FF2CAD7BQ37919998-146E42FD-F907-4EE4-B822-AA9DFA3F7DD2Q37956231-8E9A9C1B-0C3E-4F2C-9320-1BB7409F1993Q37981953-0C5A2B87-55A2-41F1-9A27-3B2FEAF391EAQ38159762-9881C9DD-BCDF-485D-BC58-F463A90B957CQ38168505-63F48422-71D7-4BE3-8F80-0ACB571A935DQ38195322-EDB50EB8-35CF-45F8-BEC4-E8E28995E0ECQ38264794-309A3A83-0DF1-4BF0-9D2E-CED988D84A98Q38599131-B4DAEDD3-DCD1-49A8-8AB4-3B78744D3077Q38651307-1BC6B8D9-A005-4BCC-9533-EF9152EF31C4Q38962035-B1301B6C-7931-4B54-B05B-A441A98973AFQ39357846-BFB9E999-F8E2-407A-9B46-4F260D5D2660Q39647789-028F740F-A43A-4210-9944-2CFB93D79664Q42951223-00049C8B-405F-4687-9689-1B478317B04DQ43169937-1ED11FD7-98CF-43EF-AD09-4757560FAC9EQ43262460-E6EA4ACC-BAAE-406F-8894-29C9BDC48B3DQ48189832-22A5545B-3582-40BF-98C3-68A95E12C9DEQ48275729-CEADAC51-7EDE-41A6-8599-D8BA6EB93208Q49953600-F598C4AC-D677-4594-AC34-EA6ACC53DB26Q50451678-928CCECD-9A96-4FCE-82B2-756F9FEB71C0Q51785654-140DABBF-C1CF-4738-A45F-8A86B6AC709AQ52092503-A515314A-8156-443F-A84D-927415CEBC4BQ53240953-815439F3-5284-401E-BDF7-E9E6AA76970C
P2860
Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells.
description
2007 nî lūn-bûn
@nan
2007 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@ast
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@en
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@nl
type
label
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@ast
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@en
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@nl
prefLabel
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@ast
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@en
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@nl
P2093
P2860
P1476
Theaflavins attenuate hepatic ...... ing AMPK in human HepG2 cells.
@en
P2093
Chih-Li Lin
Hsiu-Chen Huang
Jen-Kun Lin
P2860
P304
P356
10.1194/JLR.M700128-JLR200
P577
2007-08-24T00:00:00Z